Corporate News     17-May-21
Camlin Fine Sciences to acquires 80% stake in AlgalR NutraPharms
Camlin Fine Sciences will be acquiring 80% stake in AlgalR NutraPharms. The Company will now be executing the Investment Agreement, Share Purchase Agreement and the incidental agreements / documents with AlgalR and its promoters / other shareholders.

AlgalR provides an opportunity to the Company for expanding its footprint into the Nutraceuticals segment.

AlgalR was incorporated on 24 July 2014. It is a manufacturer of Algal Omega]3 fatty acids, particularly Docosahexaenoic acid (DHA) and Eicosapentaenoic acid (EPA) from microalgae, which are considered 100% Vegetarian. Omega]3 fatty acids play an important role in the human metabolism and has been associated with a number of health benefits. These products are manufactured in compliance with the set industrial norms, FSSAI, and ISO 22000:2005 standards using a patented technology in a state]of]the]art production system located in Southern part of India.

Previous News
  Camlin Fine Sciences allots 5,875 equity shares under ESOP
 ( Corporate News - 15-Feb-22   16:17 )
  Camlin Fine Sciences allots 26,625 equity shares under ESOP
 ( Corporate News - 21-Dec-21   18:23 )
  Camlin Fine Sciences Ltd leads losers in 'A' group
 ( Hot Pursuit - 28-Mar-24   15:00 )
  Camlin Fine Sciences schedules board meeting
 ( Corporate News - 04-Aug-22   10:45 )
  Camlin Fine Sciences advances after winning contract
 ( Hot Pursuit - 15-Nov-17   12:13 )
  Camlin Fine Sciences net profit rises 122.22% in the December 2013 quarter
 ( Results - Announcements 10-Feb-14   08:17 )
  Camlin Fine Sciences appoints director
 ( Corporate News - 26-Dec-20   11:26 )
  Camlin Fine Sciences allots 14,750 equity shares under ESOP
 ( Corporate News - 16-Mar-23   14:40 )
  Board of Camlin Fine Sciences approves preferential issue of convertible warrants
 ( Corporate News - 29-Nov-17   15:53 )
  Camlin Fine Sciences consolidated net profit declines 63.27% in the March 2020 quarter
 ( Results - Announcements 20-Jun-20   08:17 )
  Camlin Fine Sciences reports consolidated net profit of Rs 5.16 crore in the December 2019 quarter
 ( Results - Announcements 08-Feb-20   08:54 )
Other Stories
  Board of Advait Infratech approves allotment of 5.92 lakh equity shares
  04-Jul-24   13:18
  Tembo Global Industries updates on dividend
  04-Jul-24   12:54
  Max Estates secures additional FAR for its residential project in Noida
  04-Jul-24   12:19
  Greaves Cotton announces resignation of Chief Communications Officer
  04-Jul-24   12:08
  Board of IDFC recommends Interim Dividend
  04-Jul-24   12:06
  Shyam Metalics & Energy appoints director
  04-Jul-24   11:44
  Amarjothi Spinning Mills reschedules AGM date
  04-Jul-24   10:33
  Prime Capital Market to declare Quarterly Result
  04-Jul-24   10:20
  Yes Bank to hold board meeting
  04-Jul-24   10:20
  Avenue Supermarts schedules board meeting
  04-Jul-24   10:20
Back Top